Evidence map›Paper›PMID 29554978›Full record

ArticleJournal of neuroinflammation2018

Peroxiredoxin 2 activates microglia by interacting with Toll-like receptor 4 after subarachnoid hemorrhage.

Yue Lu, Xiang-Sheng Zhang, Zi-Huan Zhang, Xiao-Ming Zhou, Yong-Yue Gao, Guang-Jie Liu, Han Wang, Ling-Yun Wu, Wei Li, Chun-Hua Hang

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed, 2 pooled it
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 2 syntheses or guidelines pooled it, 151 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Yue LuDepartment of Neurosurgery, Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China.
Xiang-Sheng ZhangDepartment of Neurosurgery, Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China.
Zi-Huan ZhangDepartment of Neurosurgery, Zhongdu Hospital, Bengbu, China.
Xiao-Ming ZhouDepartment of Neurosurgery, Changzheng Hospital, Second Military Medical University, Shanghai, China.
Yong-Yue GaoDepartment of Neurosurgery, Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China.
Guang-Jie LiuDepartment of Neurosurgery, Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China.
Han WangDepartment of Neurosurgery, Jinling Hospital, School of Medicine, South Medical University, Nanjing, China.
Ling-Yun WuDepartment of Neurosurgery, Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China.
Wei LiDepartment of Neurosurgery, Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China. lwxzlw@126.com.
Chun-Hua HangDepartment of Neurosurgery, Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China. hang_neurosurgery@163.com.
Nanjing Drum Tower Hospital · CNJinling Institute of Technology · CNSecond Military Medical University · CN

Funding

National Natural Science Foundation of China 81371294National Natural Science Foundation of China 81401029National Natural Science Foundation of China 81501022
6 · The paper itself

Abstract

backgroundPeroxiredoxin (Prx) protein family have been reported as important damage-associated molecular patterns (DAMPs) in ischemic stroke. Since peroxiredoxin 2 (Prx2) is the third most abundant protein in erythrocytes and the second most protein in the cerebrospinal fluid in traumatic brain injury and subarachnoid hemorrhage (SAH) patients, we assessed the role of extracellular Prx2 in the context of SAH.

methodsWe introduced a co-culture system of primary neurons and microglia. Prx2 was added to culture medium with oxyhemoglobin (OxyHb) to mimic SAH in vitro. Neuronal cell viability was assessed by lactate dehydrogenase (LDH) assay, and neuronal apoptosis was determined by TUNEL staining. Inflammatory factors in culture medium were measured by ELISA, and their mRNA levels in microglia were determined by qPCR. Toll-like receptor 4 knockout (TLR4-KO) mice were used to provide TLR4-KO microglia; ST-2825 was used to inhibit MyD88, and pyrrolidine dithiocarbamate (PDTC) was used to inhibit NF-κB. Related cellular signals were analyzed by Western blot. Furthermore, we detected the level of Prx2 in aneurysmal SAH patients' cerebrospinal fluids (CSF) and compared its relationship with Hunt-Hess grades.

resultsPrx2 interacted with TLR4 on microglia after SAH and then activated microglia through TLR4/MyD88/NF-κB signaling pathway. Pro-inflammatory factors were expressed and released, eventually caused neuronal apoptosis. The levels of Prx2 in SAH patients positively correlated with Hunt-Hess grades.

conclusionsExtracellular Prx2 in CSF after SAH is a DAMP which resulted in microglial activation via TLR4/MyD88/NF-κB pathway and then neuronal apoptosis. Prx2 in patients' CSF may be a potential indicator of brain injury and prognosis.

Indexed as

AnimalsAnimals, NewbornAntioxidantsCerebral CortexCoculture TechniquesCytokinesGene Expression RegulationHeterocyclic Compounds, 2-RingHumansIn Situ Nick-End LabelingL-Lactate DehydrogenaseMice, Inbred C57BLMice, TransgenicMicrogliaNeuronsOxyhemoglobinsAntioxidantsCytokinesHeterocyclic Compounds, 2-RingL-Lactate DehydrogenaseOxyhemoglobinsPeroxiredoxinspyrrolidine dithiocarbamic acidPyrrolidinesRNA, MessengerSpiro CompoundsST2825ThiocarbamatesTlr4 protein, mouseToll-Like Receptor 4Microglial activationNeuronal apoptosisPeroxiredoxin 2Subarachnoid hemorrhageToll-like receptor 4

Identifiers

PMID29554978
PMCPMC5859544
OpenAlexW2806624695

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.